1. Home
  2. TNL vs ACAD Comparison

TNL vs ACAD Comparison

Compare TNL & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNL
  • ACAD
  • Stock Information
  • Founded
  • TNL 1990
  • ACAD 1993
  • Country
  • TNL United States
  • ACAD United States
  • Employees
  • TNL N/A
  • ACAD N/A
  • Industry
  • TNL Hotels/Resorts
  • ACAD Biotechnology: Pharmaceutical Preparations
  • Sector
  • TNL Consumer Discretionary
  • ACAD Health Care
  • Exchange
  • TNL Nasdaq
  • ACAD Nasdaq
  • Market Cap
  • TNL 3.6B
  • ACAD 3.4B
  • IPO Year
  • TNL N/A
  • ACAD 2004
  • Fundamental
  • Price
  • TNL $55.16
  • ACAD $19.95
  • Analyst Decision
  • TNL Buy
  • ACAD Buy
  • Analyst Count
  • TNL 10
  • ACAD 19
  • Target Price
  • TNL $62.00
  • ACAD $25.33
  • AVG Volume (30 Days)
  • TNL 545.3K
  • ACAD 1.6M
  • Earning Date
  • TNL 02-19-2025
  • ACAD 02-26-2025
  • Dividend Yield
  • TNL 3.50%
  • ACAD N/A
  • EPS Growth
  • TNL 10.24
  • ACAD N/A
  • EPS
  • TNL 5.82
  • ACAD 0.78
  • Revenue
  • TNL $3,864,000,000.00
  • ACAD $929,236,000.00
  • Revenue This Year
  • TNL $3.73
  • ACAD $36.88
  • Revenue Next Year
  • TNL $4.60
  • ACAD $8.01
  • P/E Ratio
  • TNL $9.52
  • ACAD $25.70
  • Revenue Growth
  • TNL 3.04
  • ACAD 47.06
  • 52 Week Low
  • TNL $39.91
  • ACAD $14.15
  • 52 Week High
  • TNL $58.95
  • ACAD $26.56
  • Technical
  • Relative Strength Index (RSI)
  • TNL 50.87
  • ACAD 60.25
  • Support Level
  • TNL $55.26
  • ACAD $19.52
  • Resistance Level
  • TNL $58.95
  • ACAD $20.29
  • Average True Range (ATR)
  • TNL 1.62
  • ACAD 0.68
  • MACD
  • TNL -0.04
  • ACAD 0.08
  • Stochastic Oscillator
  • TNL 38.57
  • ACAD 72.62

About TNL Travel Leisure Co. Common Stock

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts and Travel and Membership which operates a variety of travel businesses, including three vacation exchange brands, a home exchange network, travel technology platforms, travel memberships, and direct-to-consumer rentals. The majority of the revenue is earned from the United States.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Share on Social Networks: